MX9700229A - Vacuna de polinucleotido para virus de papiloma. - Google Patents
Vacuna de polinucleotido para virus de papiloma.Info
- Publication number
- MX9700229A MX9700229A MX9700229A MX9700229A MX9700229A MX 9700229 A MX9700229 A MX 9700229A MX 9700229 A MX9700229 A MX 9700229A MX 9700229 A MX9700229 A MX 9700229A MX 9700229 A MX9700229 A MX 9700229A
- Authority
- MX
- Mexico
- Prior art keywords
- papillomavirus
- polynucleotide vaccine
- papilloma virus
- expressed
- protection against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
Construcciones de ADN que codifican productos de gen de virus de papiloma, capaces de expresarse por introduccion directa hacia tejidos novedosos animales, son agentes farmacéuticos profilácticos novedosos que pueden proveer proteccion inmune contra infeccion por virus de papiloma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26842494A | 1994-06-30 | 1994-06-30 | |
PCT/US1995/006915 WO1996000583A1 (en) | 1994-06-30 | 1995-06-01 | Polynucleotide vaccine for papillomavirus |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9700229A true MX9700229A (es) | 1997-04-30 |
Family
ID=23022939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9700229A MX9700229A (es) | 1994-06-30 | 1995-06-01 | Vacuna de polinucleotido para virus de papiloma. |
Country Status (20)
Country | Link |
---|---|
US (1) | US5866553A (es) |
EP (1) | EP0768893B1 (es) |
JP (1) | JPH10501987A (es) |
CN (1) | CN1156966A (es) |
AT (1) | ATE233101T1 (es) |
AU (1) | AU701973B2 (es) |
CA (1) | CA2193365C (es) |
CZ (1) | CZ375296A3 (es) |
DE (1) | DE69529748T2 (es) |
ES (1) | ES2191052T3 (es) |
FI (1) | FI965224A (es) |
HU (1) | HU220747B1 (es) |
IL (1) | IL113817A (es) |
MX (1) | MX9700229A (es) |
NO (1) | NO965590L (es) |
NZ (1) | NZ288045A (es) |
PL (1) | PL180639B1 (es) |
SK (1) | SK164196A3 (es) |
WO (1) | WO1996000583A1 (es) |
ZA (1) | ZA954641B (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6995008B1 (en) * | 1994-03-07 | 2006-02-07 | Merck & Co., Inc. | Coordinate in vivo gene expression |
US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
FR2751879B1 (fr) * | 1996-07-30 | 1998-10-30 | Transgene Sa | Composition pharmaceutique contre les tumeurs et infections a papillomavirus |
US7118754B1 (en) | 1996-07-30 | 2006-10-10 | Transgene S.A. | Pharmaceutical composition for treating papillomavirus tumors and infection |
DE19631357A1 (de) * | 1996-08-02 | 1998-02-05 | Deutsches Krebsforsch | Vektor zur Aktivierung des Immunsystems gegen mit Papillomviren bzw. Sequenzen davon assoziierten Zellen |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US6797276B1 (en) * | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
US20060002959A1 (en) * | 1996-11-14 | 2006-01-05 | Government Of The United States | Skin-sctive adjuvants for transcutaneous immuization |
US20060002949A1 (en) * | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
EP1017283B1 (en) * | 1997-02-14 | 2004-12-15 | Merck & Co., Inc. | Polynucleotide vaccine formulations |
US6013258A (en) * | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
US6183746B1 (en) | 1997-10-09 | 2001-02-06 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
US20040258703A1 (en) * | 1997-11-14 | 2004-12-23 | The Government Of The Us, As Represented By The Secretary Of The Army | Skin-active adjuvants for transcutaneous immunization |
US7494658B2 (en) | 1998-02-20 | 2009-02-24 | Medigene Ag | Papilloma virus truncated L1 protein and fusion protein constructs |
US20020039584A1 (en) | 1998-02-20 | 2002-04-04 | Medigene Ag | Papilloma virus capsomere vaccine formulations and methods of use |
CA2229955C (en) | 1998-02-20 | 2003-12-09 | Medigene Gmbh | Papilloma virus capsomere vaccine formulations and methods of use |
US7182947B2 (en) | 1998-02-20 | 2007-02-27 | Medigene Ag | Papillomavirus truncated L1 protein and fusion protein constructs |
US6926897B1 (en) | 1998-03-24 | 2005-08-09 | Medigene Aktiengesellschaft | Medicament for the avoidance or treatment of papillomavirus-specific tumour |
EP1071377A1 (en) * | 1998-04-14 | 2001-01-31 | Merck & Co., Inc. | Needleless administration of polynucleotide formulations |
NZ510488A (en) * | 1998-09-04 | 2003-07-25 | Aventis Pasteur | Immunotherapy for HPV DNA-positive cervical cancers with DNA constructs for the administration of HPV antigens to provide an immune response in a host |
US20020054914A1 (en) * | 1999-02-03 | 2002-05-09 | Tulin Morcol | Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein |
US20040258763A1 (en) * | 1999-02-03 | 2004-12-23 | Bell Steve J.D. | Methods of manufacture and use of calcium phosphate particles containing allergens |
US6355271B1 (en) * | 1999-02-03 | 2002-03-12 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of manufacture and use |
ES2308069T3 (es) * | 1999-03-26 | 2008-12-01 | Vical Incorporated | Composiciones adyuvantes para realzar inmunorespuestas a las vacunas polinucleotido-basadas. |
AU4188100A (en) * | 1999-04-08 | 2000-11-14 | Gregory M. Glenn | Dry formulation for transcutaneous immunization |
ATE284898T1 (de) * | 1999-08-25 | 2005-01-15 | Merck & Co Inc | Synthetische papillomavirus gene, welche für expression in menschlichen zellen optimiert sind |
US7001995B1 (en) | 1999-08-25 | 2006-02-21 | Merck & Co., Inc. | Synthetic human papillomavirus genes |
KR100366608B1 (ko) * | 2000-02-15 | 2003-01-09 | 마스터진(주) | 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신 |
US20020044948A1 (en) * | 2000-03-15 | 2002-04-18 | Samir Khleif | Methods and compositions for co-stimulation of immunological responses to peptide antigens |
SE0002498D0 (sv) * | 2000-07-03 | 2000-07-03 | Stefan Schwartz | Papillomavirus vaccine |
KR20020005332A (ko) * | 2000-07-10 | 2002-01-17 | 정상훈 | 탈모증 치료용 키트 |
PT1372708E (pt) * | 2001-02-13 | 2008-09-29 | Us Gov Sec Army | Vacina para imunização transcutânea |
US20040241181A1 (en) * | 2001-06-22 | 2004-12-02 | Ertl Hildeghund C. J. | Methods of inducing a cytotoxic immune response and recormbinant simian adenovirus compositions useful therein |
DE10137102A1 (de) * | 2001-07-30 | 2003-02-27 | Deutsches Krebsforsch | Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung |
US20030185892A1 (en) * | 2001-08-17 | 2003-10-02 | Bell Steve J. D. | Intraocular delivery compositions and methods |
US20030228327A1 (en) * | 2001-11-05 | 2003-12-11 | Lasher Alfred W. | DNA-based plasmid formulations and vaccines and prophylactics containing the same |
ES2618309T3 (es) * | 2002-12-13 | 2017-06-21 | Alphavax, Inc. | Partículas de replicón de alfavirus multi-antigénico y métodos |
AU2005219372A1 (en) * | 2004-02-13 | 2005-09-15 | Safeway Investments Ltd. | Therapeutic calcium phosphate particles and methods of making and using same |
US20090041812A1 (en) * | 2004-11-01 | 2009-02-12 | Bell Steve J D | Therapeutic Calcium Phosphate Particles in Use for Aesthetic of Cosmetic Medicine, and Methods of Manufacture and Use |
AU2006210792B2 (en) * | 2005-02-01 | 2012-07-26 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies |
CN101570571B (zh) | 2007-04-29 | 2012-07-11 | 北京万泰生物药业股份有限公司 | 截短的人乳头瘤病毒18型l1蛋白 |
BRPI0811016B1 (pt) * | 2007-04-29 | 2021-09-21 | Xiamen Innovax Biotech Co., Ltd. | Proteína li truncada do papiloma vírus humano tipo 16 |
DK2154149T3 (da) * | 2007-05-29 | 2019-10-14 | Univ Xiamen | En trunkeret l1-protein af human papillomavirus 6 |
KR20150128900A (ko) * | 2013-03-15 | 2015-11-18 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 항원 및 어쥬번트로서 인터류킨-23을 갖는 백신 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4497796A (en) * | 1980-03-26 | 1985-02-05 | The Regents Of The University Of California | Gene transfer in intact mammals |
ATE79138T1 (de) * | 1985-04-04 | 1992-08-15 | Univ Georgetown | Typenspezifische papillomavirus-dns-sequenzen und peptide. |
US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
WO1990011092A1 (en) * | 1989-03-21 | 1990-10-04 | Vical, Inc. | Expression of exogenous polynucleotide sequences in a vertebrate |
ATE332973T1 (de) * | 1991-07-19 | 2006-08-15 | Univ Queensland | Polynukleotidabschnitt des hpv16-genoms |
US5376542A (en) * | 1992-04-27 | 1994-12-27 | Georgetown University | Method for producing immortalized cell lines using human papilluma virus genes |
EP0586076B1 (en) * | 1992-08-07 | 2003-06-25 | Wyeth | Recombinant adenovirus vaccines |
US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
-
1995
- 1995-05-22 IL IL11381795A patent/IL113817A/en not_active IP Right Cessation
- 1995-06-01 CA CA002193365A patent/CA2193365C/en not_active Expired - Fee Related
- 1995-06-01 SK SK1641-96A patent/SK164196A3/sk unknown
- 1995-06-01 DE DE69529748T patent/DE69529748T2/de not_active Expired - Fee Related
- 1995-06-01 US US08/750,810 patent/US5866553A/en not_active Expired - Fee Related
- 1995-06-01 AU AU26945/95A patent/AU701973B2/en not_active Ceased
- 1995-06-01 ES ES95922160T patent/ES2191052T3/es not_active Expired - Lifetime
- 1995-06-01 CZ CZ963752A patent/CZ375296A3/cs unknown
- 1995-06-01 MX MX9700229A patent/MX9700229A/es unknown
- 1995-06-01 HU HU9603562A patent/HU220747B1/hu not_active IP Right Cessation
- 1995-06-01 CN CN95194672A patent/CN1156966A/zh active Pending
- 1995-06-01 AT AT95922160T patent/ATE233101T1/de not_active IP Right Cessation
- 1995-06-01 JP JP8503166A patent/JPH10501987A/ja active Pending
- 1995-06-01 EP EP95922160A patent/EP0768893B1/en not_active Expired - Lifetime
- 1995-06-01 WO PCT/US1995/006915 patent/WO1996000583A1/en active IP Right Grant
- 1995-06-06 ZA ZA954641A patent/ZA954641B/xx unknown
-
1996
- 1996-12-18 PL PL95317874A patent/PL180639B1/pl unknown
- 1996-12-18 NZ NZ288045A patent/NZ288045A/en unknown
- 1996-12-27 FI FI965224A patent/FI965224A/fi unknown
- 1996-12-27 NO NO965590A patent/NO965590L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1156966A (zh) | 1997-08-13 |
WO1996000583A1 (en) | 1996-01-11 |
CA2193365C (en) | 2007-04-03 |
HU220747B1 (hu) | 2002-05-28 |
NZ288045A (en) | 1998-08-26 |
ES2191052T3 (es) | 2003-09-01 |
NO965590L (no) | 1997-02-28 |
EP0768893A1 (en) | 1997-04-23 |
HU9603562D0 (en) | 1997-02-28 |
PL317874A1 (en) | 1997-04-28 |
FI965224A0 (fi) | 1996-12-27 |
CZ375296A3 (en) | 1997-08-13 |
AU701973B2 (en) | 1999-02-11 |
PL180639B1 (pl) | 2001-03-30 |
ZA954641B (en) | 1996-01-26 |
NO965590D0 (no) | 1996-12-27 |
AU2694595A (en) | 1996-01-25 |
US5866553A (en) | 1999-02-02 |
HUT76446A (en) | 1997-09-29 |
EP0768893B1 (en) | 2003-02-26 |
IL113817A (en) | 2001-03-19 |
SK164196A3 (en) | 1997-08-06 |
ATE233101T1 (de) | 2003-03-15 |
FI965224A (fi) | 1996-12-27 |
IL113817A0 (en) | 1995-08-31 |
DE69529748D1 (de) | 2003-04-03 |
DE69529748T2 (de) | 2003-10-16 |
JPH10501987A (ja) | 1998-02-24 |
CA2193365A1 (en) | 1996-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9700229A (es) | Vacuna de polinucleotido para virus de papiloma. | |
YU12894A (sh) | Farmaceutski preparat na bazi nukleinske kiseline | |
WO1996010419A3 (en) | Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule | |
IL131131A0 (en) | Synthetic hiv gag genes | |
WO1996011279A3 (en) | Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system | |
WO2000075336A3 (fr) | Fragment proteiques polyepitopiques des proteines e6 et e7 de hpv, leur obtention et leurs utilisations notamment en vaccination | |
PT1212358E (pt) | Genes sinteticos de papilomavirus humano | |
HK1034039A1 (en) | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines | |
EP1728863A3 (en) | C-class oligonucleotide analogs with enhanced immunostimulatory potency | |
AU6117696A (en) | Nucleic acid respiratory syncytial virus vaccines | |
NZ331161A (en) | Synthetic HIV genes encoding envelope (env) proteins | |
ATE420190T1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
WO2002087494A3 (en) | Novel vaccine | |
HU9201746D0 (en) | Recombinant avipox virus, the virus infected cell cultivation and the vaccine resulted from it for poultry vaccination | |
ATE285239T1 (de) | Dna enthaltende impfstoffen | |
WO1997005899A3 (en) | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same | |
EP0868522A4 (en) | RECOMBINANT POX VIRUS OF INFECTIOUS PERITONITIS OF THE CAT, COMPOSITIONS THEREOF AND METHODS FOR THE PRODUCTION AND USE | |
IL148741A0 (en) | Vaccine | |
WO2000052045A3 (en) | Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof | |
AU8405798A (en) | A swine hepatitis e virus and uses thereof | |
AU1871501A (en) | Liposomes | |
PL370854A1 (en) | Ee3-protein family and corresponding dna sequences | |
NZ333563A (en) | Growth arrest gene (B4B) compositions resulting in the inhibition of cellular proliferation | |
AU7728296A (en) | Hemoregulatory compounds | |
MX9709347A (es) | Micoplasma synoviae no virulento y vacuna del mismo. |